1. Home
  2. DNUT vs IRWD Comparison

DNUT vs IRWD Comparison

Compare DNUT & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.61

Market Cap

585.5M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.44

Market Cap

526.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
IRWD
Founded
1937
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
585.5M
526.7M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
DNUT
IRWD
Price
$3.61
$4.44
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$4.72
$7.67
AVG Volume (30 Days)
1.7M
1.8M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
0.99%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.15
Revenue
$1,522,616,000.00
$298,276,000.00
Revenue This Year
$0.55
$57.95
Revenue Next Year
$3.59
$4.39
P/E Ratio
N/A
$28.87
Revenue Growth
N/A
8.88
52 Week Low
$2.58
$0.55
52 Week High
$5.73
$5.78

Technical Indicators

Market Signals
Indicator
DNUT
IRWD
Relative Strength Index (RSI) 59.69 67.36
Support Level $3.17 $3.07
Resistance Level $3.87 $5.67
Average True Range (ATR) 0.14 0.23
MACD 0.02 0.14
Stochastic Oscillator 91.46 95.52

Price Performance

Historical Comparison
DNUT
IRWD

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: